Literature DB >> 23592919

Association of the del443ins54 at the ARMS2 locus in Indian and Australian cohorts with age-related macular degeneration.

Inderjeet Kaur1, Stuart Cantsilieris, Saritha Katta, Andrea J Richardson, Maria Schache, Rajeev R Pappuru, Raja Narayanan, Annie Mathai, Ajit B Majji, Nicole Tindill, Robyn H Guymer, Subhabrata Chakrabarti, Paul N Baird.   

Abstract

PURPOSE: The ARMS2/HTRA1 genes at the 10q26 locus have been associated with risk of age-related macular degeneration (AMD), with the most significantly associated variants being A69S (rs10490924), del443ins54 (EU427539) and rs11200638. We wished to explore the association of the del443ins54 in two ethnically different populations from India and Australia.
METHODS: The del443ins54 was screened in a large cohort of ~1500 subjects from these two populations by a combination of PCR-based agarose gel electrophoresis and validated by resequencing. Statistical analysis comprised the calculations of allele, genotype and haplotype frequencies along with their p values and corresponding odds ratios (OR), and 95% confidence intervals (95% CI) and measures of linkage disequilibrium (LD).
RESULTS: The del443ins54 was significantly associated with AMD in both the Indian (p=1.74 × 10(-13); OR = 2.80, 95%CI, 2.12-3.70) and Australian cohorts (p = 2.78 × 10(-30); OR = 3.15, 95%CI, 2.58-3.86). These associations were similar to those previously identified for the A69S and the rs11200638 variant in these populations that also exhibited high degrees of LD (D' of 0.87-0.99). A major risk haplotype of "T-indel-A" (p = 5.7 × 10(-16); OR = 3.16, 95%CI, 2.34-4.19 and p=6.33 × 10(-30); OR = 3.15, 95%CI, 2.57-3.85) and a protective haplotype of "G-wild type-G" (p=2.35 × 10(-11); OR = 0.39, 95%CI, 0.29-0.52 and p=1.02 × 10(-30); OR = 0.31, 95%CI, 0.25-0.38) were identified in the Indian and Australian cohorts, respectively.
CONCLUSIONS: These data provide an independent replication of the association of del443ins54 variant in two different ethnicities, despite differences in allele and haplotype frequencies between them. High levels of LD in both populations limit further genetic dissection of this region in AMD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592919      PMCID: PMC3626282     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


Introduction

Age-related macular degeneration (AMD) is a complex multifactorial disease and a leading cause of irreversible blindness in the world [1]. A major AMD susceptibility locus on 10q26 has been found to harbor risk associated variants in ARMS2 (rs10490924) and HTRA1 (rs11200638) in multiple populations worldwide [1-4]. An insertion-deletion (indel) polymorphism (EU427539) that affects the stability of ARMS2 mRNA by the removal of a polyadenylation signal (443 bases) and insertion of a 54bp AU rich element in the 3′-UTR (del443ins54), has also been identified in the 3′ end of the ARMS2 gene as increasing risk of AMD by several fold in both Caucasian [5] as well as Asian populations. Previous associations for this indel vary (from p=3.5×10−5 to p=8.4×10−34) in individuals of European origin [6-9], whereas, this has only been reported in two non-European cohorts consisting of Han Chinese [8] and Japanese populations [10]. We have previously reported a significant association of the A69S (rs10490924) and rs11200638 variants with AMD in both South Indian and Australian cohorts [11,12]. We now wished to determine the risk conferred by del443ins54 and its combined effect with both the A69S and rs11200638 variants with AMD susceptibility in two ethnically different cohorts from Southern India and Australia.

Methods

The study protocols adhered to the tenets of the Declaration of Helsinki and were approved by the Institutional Review Boards of the Royal Victorian Eye and Ear Hospital, Melbourne, Australia and L.V. Prasad Eye Institute, Hyderabad, India. The del443ins54 was screened in end stage AMD cases (mainly choroidal neovascular) and normal controls from cohorts in India (n=433) and Australia (n=1054). The detailed methods of clinical diagnosis along with the inclusion and exclusion criteria have been previously reported [11,12]. Amplification was performed using forward (5′-TCT GTG CAG CTG GTG AAA TC-3′) and reverse (5′-TCC AGG GTG GTG TAA TCC AT-3′) primers at an annealing temperature of 61 °C. Amplicons were visualized on a 2% agarose gel and genotypes directly scored from the gels. Subsets of samples were further validated by bi-directional sequencing on an automated DNA sequencer (ABI 3100), using the BigDye chemistry as per manufacturer’s guidelines (both from Applied Biosystems, Foster City, CA). Genotyping results were independently validated by a second investigator who was masked to the phenotype data. Allele and genotype frequencies were determined by the gene counting method and estimates of Hardy–Weinberg equilibrium were assessed. Odds ratios (OR) and 95% confidence intervals (95%CI) were calculated to assess the risk conferred for each variant using the PLINK software [13]. Haplotypes were generated using various combinations of the A69S, the indel and rs11200638 variants and the estimated haplotype frequencies and linkage disequilibrium (LD) were assessed with the Haploview software (version 4.2) that uses the EM algorithm [14].

Results

All statistical analyses were based on samples where genotyping was successful across all three A69S, del443ins54 and rs11200638 genetic variants. Each variant was in Hardy–Weinberg equilibrium in both the Indian and Australian cohorts (p>0.05). Allele frequencies for each of the risk variants (T allele of A69S, presence of the indel in del443ins54 and the A allele of rs11200638) exhibited a relatively higher frequency (0.60–0.63) in the Indian cohort compared to the European cohorts (0.36–0.53) but lesser than that reported in Han Chinese (0.73–0.77) or the in the Japanese (0.86–0.88) populations (Table 1). The allele frequencies in the Australian cohort were similar (0.44) to those previously reported for other European cohorts (Table 1).
Table 1

Risk allele frequencies of the ARMS2 (A69S and del443ins54) and HTRA1 SNPs in different populations.

Population
(N=Cases, Controls)rs10490924 (A69S; “T” risk allele)
del443ins54 (Indel)
rs11200638 (“A” risk allele)
CaseControlP valueOR (95%CI)CasesControlsP valueOR(95%CI)CasesControlsP valueOR (95%CI)
German (760, 549)5
0.424
0.193
2.8 x10-29
2.86(2.38-3.44)
0.424
0.193
4.1 x10-29
2.85(2.37-3.43)
0.426
0.199
6.9 x 10-29
2.85(2.37-3.42)
Caucasian (819, 329)6
0.412
0.248
1.89 x 10-13
2.13 (1.74-2.61)
0.409
0.248
3.62 x 10-13
2.1 (1.71-2.57)
NA
NA
NA
NA
Caucasian (291, 191)7
0.36
0.23
3.31 x 10-5
1.86
0.36
0.23
3.46 x 10-5
1.85
0.36
0.24
6.41 x 10-5
1.8
Utah (705, 650)8
0.38
0.2
8.61 x 10-26
NA
0.39
0.2
1.9 x 10-26
NA
0.41
0.22
3.64 x 10-26
NA
Northern European (442, 434)8
0.52
0.24
4.87 x 10-34
NA
0.53
0.25
8.35x10-34
NA
0.53
0.25
2.52 x 10-34
NA
Italian (159, 286)9
NA
NA
NA
NA
0.51
0.24
2.7x10-15
3.25 (2.36-4.41)
NA
NA
NA
NA
Han Chinese (138, 591)8
0.74
0.49
1.15 x 10-13
NA
0.73
0.49
6.03 x 10-13
NA
0.77
0.52
5.10 x 10-13
NA
Japanese (56, 77)10
0.86
0.62
NA
NA
0.875
0.66
NA
NA
NA
NA
NA
NA
Australian (624,430)*
0.445
0.202
1.97x10-30
3.14(2.58-3.86)
0.446
0.199
2.78x10-30
3.15 (2.58-3.86)
0.441
0.202
1.43x10-29
3.11(2.54-3.80)
South Indian (227, 206)*0.630.361.85x10-153.06 (2.31-4.04)0.630.381.74x10-132.8 (2.12-3.70)0.60.359.11x10-112.76 (2.02-3.77)

*Data from the current study ; NA = Data not available

*Data from the current study ; NA = Data not available The frequency of the del443ins54 variant was significantly higher among AMD cases than controls in both the Indian (p=1.74×10−13; OR=2.80, 95%CI, 2.12–3.70) and Australian (p=2.78×10−30; OR=3.15, 95%CI, 2.58–3.86), cohorts (Table 1). This increased risk was also observed with respect to the del443ins54 genotypes. These findings were similar for the A69S (ARMS2) and the rs11200638 (HTRA1) variants in both the Indian and Australian cohorts, respectively (Table 2).
Table 2

Genotype counts of the ARMS2 and HTRA1 SNPs in the Indian and Australian cohorts

PopulationSNP (gene)GenotypesGenotype counts
P valueOdds ratios (95% CI)
CasesControls
Australian
rs10490924 (ARMS2)
GG
189
271
-
Ref
GT
282
138
<0.0001
2.93 (2.22 - 3.86)
TT
145
16
<0.0001
12.99 (7.51 - 22.49)
Indel -EU427539 (ARMS2)
Wt/Wt
190
269
-
Ref
Wt/Indel
306
137
<0.0001
3.16 (2.41 - 4.16)
Indel/Indel
119
15
<0.0001
11.23 (6.36 – 19.82)
rs11200638 (HTRA1)
GG
194
271
-
Ref
GA
292
138
<0.0001
2.96 (2.25 – 3.89)
AA
130
17
<0.0001
10.68 (6.24 – 18.29)
Indianrs10490924 (ARMS2)
GG
39
85
-
Ref
GT
84
94
0.004
1.95 (1.21 – 3.15)
TT
99
26
<0.0001
8.30 (4.67 – 14.74)
Indel -EU427539 (ARMS2)
Wt/Wt
44
84
-
Ref
Wt/Indel
79
88
0.017
1.71 (1.16 – 2.75)
Indel/Indel
104
34
<0.0001
5.84 (3.43 – 9.94)
rs11200638 (HTRA1)GG
44
61
-
Ref
GA
70
67
0.01
1.45 (0.87 – 2.42)
AA8417<0.00016.85 (3.58 – 13.12)
Homozygosity of the indel and the other variants were strongly associated with an increased risk of AMD in both the Indian and Australian cohorts. Combined homozygosities at the A69S and the rs11200638 along with the indel variant did not alter the risk of AMD significantly either in the Indian (OR=7.69, 95%CI, 4.07–14.51) or Australian cohorts (OR=10.61, 95%CI, 7.05–15.96). The measure of linkage disequilibrium (LD) between the A69S, del443ins54 and rs11200638 variants were remarkably high across this 10q26 region with relatively higher values in the Australian (D’=0.99; r2=0.98) compared to the Indian (D’=0.87; r2=0.71) cohorts (Figure 1). Two major haplotypes (frequency >5%) were identified across the three variants with “T-Indel-A” being the risk haplotype and “G-WT (wild-type)-G” being protective in the Indian and Australian cohorts, respectively (Table 3). Different pairwise haplotype combinations with either the ‘T’ or ‘A’ allele at A69S in presence of the del443ins54 or its wild-type form along with the ‘G’ or ‘A’ allele of rs11200638, did not substantially alter the p values or ORs observed for either the risk or protective haplotypes as opposed to when all three variants were assessed together, reinforcing the observation of the high LD between variants in these two genes (Table 3).
Figure 1

Linkage disequilibrium plots showing the three variants in the Australian and Indian cohorts. The D’ and r2 values between the SNPs are indicated inside the quadrants for the Australian (A and B) and the Indian (C and D), respectively.

Table 3

Major haplotype frequencies at the three loci harboring the ARMS2 (A69S and del443ins54) and HTRA1 variants in the Indian and Australian cohorts

HAPLOTYPES (5’-3’)

SOUTH INDIAN COHORT (n=433)
AUSTRALIAN COHORT (n=1054)
rs1094924 (ARMS2)del443ins54 (ARMS2)rs11200638 (HTRA1)% Cases
(N=227)% Controls (N=206)P valuesOR (95%CI)% Cases (N=624)% Controls (N=430)P valuesOR (95%CI)
T
Indel
A
57.8
30.3
5.70x10-16
3.16 (2.34-4.19)
44.1
20
6.33x10-30
3.15 (2.57-3.85)
G
Wt*
G
33
55.6
2.35x10-11
0.39 (0.29-0.52)
55.3
79.8
1.02x10-30
0.31 (0.25-0.38)
G
-
G
35.8
59.5
4.49x10-12
0.38 (0.29-0.50)
55.4
79.8
1.43x10-30
0.31 (0.26-0.38)
T
-
A
58.4
30.4
1.82x10-16
3.20 (2.42-4.25)
44.1
20.2
1.55x10-29
3.11 (2.55-3.81)
T
Indel
-
59.1
31.8
1.32x10-15
3.09 (2.34-4.10)
44.4
20
1.18x10-30
3.19 (2.61-3.91)
G
Wt*
-
33.5
50.4
2.54x10-13
0.36 (0.27-0.47)
55.4
79.8
1.43x10-30
0.31 (0.26-0.38)
-
Indel
A
50.8
31.8
2.41x10-15
3.06 (2.31-4.05)
44.1
20
6.33x10-30
3.15 (2.57-3.86)
-Wt*G35.559.15.04x10-120.38 (0.29-0.50)55.379.81.02x10-300.31 (0.26-0.38)

Combinations of the risk alleles at the three loci are bolded; *Wt = wildtype

Linkage disequilibrium plots showing the three variants in the Australian and Indian cohorts. The D’ and r2 values between the SNPs are indicated inside the quadrants for the Australian (A and B) and the Indian (C and D), respectively. Combinations of the risk alleles at the three loci are bolded; *Wt = wildtype

Discussion

These data provide an independent replication of the association of the ARMS2 del443ins54 variant in two cohorts, and to the best of our knowledge for the first time among South Indians with AMD. The strong association of the del443ins54 along with the A69S and rs11200638 variants in the Indian and Australian cohorts were consistent with that observed in other populations [6-10]. Haplotype analysis with these three variants indicated that inclusion of del443ins54 in the haplotype neither increased nor decreased the risk of AMD in either cohort (Table 3). The ARMS2 and HTRA1 genes are in high LD in European populations and thus dissecting out the role of one gene over the other has proved difficult. The advantage of undertaking a comparative analysis of genetic variants in populations of differing ethnicities expands the genetic diversity available and may provide the opportunity of identifying a more defined but associated region for further study. The current study highlighted similar degrees of associations across these three variants despite a relatively lower LD between the A69S, del443ins54 and rs11200638 variants in the Indian compared to the Australian cohort. However, it did confirm the presence of stratification differences between ethnicities with the allele frequency of the Indel of del443ins54 in South Indians being higher at 0.63 in cases compared to that in European populations (0.36–0.53) but lower than other Asian populations (0.73–0.88). The allele frequency in cases is similar to that previously shown by us in the assessment of the A69S (0.63) and the rs11200638 (0.60) variants of the ARMS2 and HTRA1 genes respectively, in the South Indian cohort. Evidence of population stratification has also been observed in AMD studies of the protective CFHR3–1 deletion, with the highest frequencies of the deleted allele being present in African populations (16%–20%) compared to Asians (<2%) [15,16]. The potential role of the ARMS2 and HTRA1 gene in AMD is still unclear but functional dissection of the effect of the rs11200638 promoter variant in the HTRA1 gene has revealed that this variant resides within a putative transcription binding site for the factors AP2α and SRF (serum response factor) [3,4]. Initial investigation of the influence of the homozygous risk genotype on HTRA1 expression levels revealed consistently higher levels of expression with the AA genotype compared to the GG genotype [3,4]. In contrast, other studies of the rs11200638 variant have revealed no functional effect on HTRA1 expression [2,6,17]. Analysis of the chromosome 10q26 risk haplotype inclusive of the ARMS2 del443ins54 indel found decreased ARMS2 expression and almost 3.0 fold increase in HTRA1 expression [18]. Interestingly, a subsequent study has shown that while the ARMS2 risk del443ins54 results in decrease in mRNA transcription levels of the ARMS2 gene, a non risk associated variant (rs2736911) also leads to significantly reduced ARMS2 transcript levels suggesting that ARMS2 protein deficiency alone is unlikely to be pathogenic in AMD [17]. A functional role for ARMS2 in mitochondrial homeostasis has also been suggested and the biology concerning mitochondrial dysfunction and the effects on age supports this notion [2,5]. However, subsequent immunofluorescence and immunoblot experiments localized ARMS2 in retinal epithelial ARPE-19 cells and COS7 transfected cells to the cytosol rather than the mitochondria suggesting that ARMS2 may not confer risk to AMD through the mitochondrial pathway [19]. Studies concerning the effects of AMD risk variants on HTRA1 expression are equivocal and further investigations on the functional role of these variants are required. In conclusion, we provide convincing evidence for the association of the del443ins54 variant with AMD, despite differences in allele, genotype and haplotype frequencies and LD across the 10q26 region reflecting population stratification differences in two different ethnicities. AMD, a complex multi-factorial disease is associated with multiple genomic regions with varying magnitudes of effect and the relevance of genetic associations differ between populations. Further, elucidation of the genetic basis of this disease through the analysis of individuals from different ethnic groups has the potential to provide useful insights into the genetic diversity of risk and protective variants within a gene as well as their contributions to disease. Also, meaningful genetic dissection of the ARMS2 and HTRA1 gene in this region will require much larger patient cohorts than have currently been assessed, or through the identification of other ethnic populations which show relatively lower levels of LD over this 10q26 region.
  19 in total

1.  An intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene indicates association with age-related macular degeneration.

Authors:  Andrea J Richardson; F M Amirul Islam; Khin Zaw Aung; Robyn H Guymer; Paul N Baird
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

Review 2.  Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.

Authors:  Anand Swaroop; Kari Eh Branham; Wei Chen; Goncalo Abecasis
Journal:  Hum Mol Genet       Date:  2007-10-15       Impact factor: 6.150

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26.

Authors:  Dexter Hadley; Anton Orlin; Gary Brown; Alexander J Brucker; Allen C Ho; Carl D Regillo; Larry A Donoso; Lifeng Tian; Brian Kaderli; Dwight Stambolian
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

5.  Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration.

Authors:  Gaofeng Wang; Kylee L Spencer; William K Scott; Patrice Whitehead; Brenda L Court; Juan Ayala-Haedo; Ping Mayo; Stephen G Schwartz; Jaclyn L Kovach; Paul Gallins; Monica Polk; Anita Agarwal; Eric A Postel; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Hum Genet       Date:  2010-02-25       Impact factor: 4.132

6.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.

Authors:  Gregory S Hageman; Lisa S Hancox; Andrew J Taiber; Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Monte J Radeke; David Kavanagh; Anna Richards; John Atkinson; Seppo Meri; Julie Bergeron; Jana Zernant; Joanna Merriam; Bert Gold; Rando Allikmets; Michael Dean
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

7.  Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration.

Authors:  Zhenglin Yang; Zongzhong Tong; Yuhong Chen; Jiexi Zeng; Fang Lu; Xufang Sun; Chao Zhao; Kevin Wang; Lisa Davey; Haoyu Chen; Nyall London; Daisuke Muramatsu; Francesca Salasar; Ruben Carmona; Daniel Kasuga; Xiaolei Wang; Matthew Bedell; Manjuxia Dixie; Peiquan Zhao; Ruifu Yang; Daniel Gibbs; Xiaoqi Liu; Yan Li; Cai Li; Yuanfeng Li; Betsy Campochiaro; Ryan Constantine; Donald J Zack; Peter Campochiaro; Yinbin Fu; Dean Y Li; Nicholas Katsanis; Kang Zhang
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

8.  ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Norimoto Gotoh; Hideo Nakanishi; Hisako Hayashi; Ryo Yamada; Atsushi Otani; Akitaka Tsujikawa; Kenji Yamashiro; Hiroshi Tamura; Masaaki Saito; Kuniharu Saito; Tomohiro Iida; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2009-03-09       Impact factor: 5.258

9.  Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population.

Authors:  Federico Ricci; Stefania Zampatti; Francesca D'Abbruzzi; Filippo Missiroli; Claudia Martone; Tiziana Lepre; Ilenia Pietrangeli; Cecilia Sinibaldi; Cristina Peconi; Giuseppe Novelli; Emiliano Giardina
Journal:  Arch Ophthalmol       Date:  2009-10

10.  Diversity of human copy number variation and multicopy genes.

Authors:  Peter H Sudmant; Jacob O Kitzman; Francesca Antonacci; Can Alkan; Maika Malig; Anya Tsalenko; Nick Sampas; Laurakay Bruhn; Jay Shendure; Evan E Eichler
Journal:  Science       Date:  2010-10-29       Impact factor: 47.728

View more
  4 in total

1.  Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration.

Authors:  Supanji Supanji; Dewi Fathin Romdhoniyyah; Muhammad Bayu Sasongko; Angela Nurini Agni; Firman Setya Wardhana; Tri Wahyu Widayanti; Muhammad Eko Prayogo; Ayudha Bahana Ilham Perdamaian; Aninditta Dianratri; Masashi Kawaichi; Chio Oka
Journal:  Clin Ophthalmol       Date:  2021-03-11

2.  Expression analysis of an evolutionarily conserved alternative splicing factor, Sfrs10, in age-related macular degeneration.

Authors:  Devi Krishna Priya Karunakaran; Abdul Rouf Banday; Qian Wu; Rahul Kanadia
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

Review 3.  Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.

Authors:  Francesco Parmeggiani; Francesco S Sorrentino; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Katia De Nadai; Elia Bonomo Roversi; Paola Franceschelli; Adolfo Sebastiani; Michele Rubini
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

4.  HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects.

Authors:  Ying Liu; Huipeng Jin; Dong Wei; Wenxiu Li
Journal:  BMC Med Genet       Date:  2020-05-15       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.